Skip to main content Accessibility help
×
×
Home
  • Print publication year: 2013
  • Online publication date: May 2013

6 - Psychotic depression

from Section 2 - Medical management
Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Clinical Handbook for the Management of Mood Disorders
  • Online ISBN: 9781139175869
  • Book DOI: https://doi.org/10.1017/CBO9781139175869
Please enter your name
Please enter a valid email address
Who would you like to send this to *
×

References

Akiskal, P., Walker, V.R., Puzantian, D.et al. (1983). Bipolar outcome in the course of depressive illness. Journal of Affective Disorders, 5, 115–128.
American Psychiatric Association (1968). Diagnostic and Statistical Manual of Mental Disorders, Second Edition (DSM II). Washington DC: American Psychiatric Association.
American Psychiatric Association (1980). Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM III). Washington DC: American Psychiatric Association.
American Psychiatric Association (2000). Practice guideline for the treatment of patients with major depressive disorder (revision). American Journal of Psychiatry, 157 Suppl 4, 1–45.
American Psychiatric Association (2010). Practice Guideline for the Treatment of Patients with Major Depressive Disorder, Third Edition. Washington DC: American Psychiatric Association.
Andreescu, C., Mulsant, B.H., Peasley-Miklus, C.et al. (2007). Persisting low use of antipsychotic the treatment of major depression with psychotic features. Journal of Clinical Psychiatry, 68, 194–200.
Aronson, T.A., Shukla, S., Gujavarty, K.et al. (1988). Relapse in delusional depression: A retrospective study of the course of treatment. Comprehensive Psychiatry, 29, 12–21.
Avery, D. and Lubrano, A. (1979). Depression treated with imipramine and ECT: The DeCarolis study reconsidered. American Journal of Psychiatry, 136, 559–562.
Baldwin, R.C. (1988). Delusional and non-delusional depression in late life: Evidence for distinct subtypes. British Journal of Psychiatry, 153, 39–44.
Belanoff, J.K., Flores, B.H., Kalezhan, M.et al. (2001). Rapid reversal of psychotic depression using mifepristone. Journal of Clinical Psychopharmacology, 21, 516–521.
Belanoff, J.K., Rothschild, A.J., Cassidy, F.et al. (2002). An open label trial of C-1073 (mifepristone) for psychotic major depression. Biological Psychiatry, 52, 386–392.
Birkenhager, T.K., Van den Broek, W.W., Mulder, P.G.et al. (2005). One year outcome of psychotic depression after ECT. Journal of ECT, 21, 221–226.
Birkenhager, T.K., Van den Broek, W.W., Mulder, P.G.et al. (2008). Efficacy of imipramine in psychotic versus nonpsychotic depression. Journal of Clinical Psychopharmacology, 28, 166–170.
Blasey, C.M., Block, C.M., Belanoff, J.K.et al. (2011). Efficacy and safety of mifepristone for the treatment of psychotic depression. Journal of Clinical Psychopharmacology, 31, 436–440.
Bruijn, A.J., Moleman, P., Mulder, P.G.H.et al. (1996). A double-blind fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients. Psychopharmacology, 127, 231–237.
Buchanan, H., Johnstone, E., McPherson, K. et al. (1992). Who benefits from electroconvulsive therapy? Combined results from the Leicester and Northwick Park Trials. British Journal of Psychiatry, 160, 355–359.
Chan, C.H., Janicak, P.G., Davis, J.M.et al. (1987). Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. Journal of Clinical Psychiatry, 48, 197–200.
Charney, D.S. and Nelson, J.C. (1981). Delusional and nondelusional unipolar depression: Further evidence for distinct subtypes. American Journal of Psychiatry, 138, 328–333.
Coryell, W. (1998). The treatment of psychotic depression. Journal of Clinical Psychiatry, 59 suppl 1, 22–27.
Coryell, W., Zimmerman, M., and Pfohl, B. (1986). Outcome at discharge and six months in major depression: The significance of psychotic features. Journal of Nervous and Mental Disease, 174, 92–96.
Coryell, W., Leon, A., Winokur, G.et al. (1996). Importance of psychotic symptoms to long-term course of major depression. American Journal of Psychiatry, 153, 483–489.
DeBattista, C., Belanoff, J., Glass, S.et al. (2006). Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression. Biological Psychiatry, 60, 1343–1349.
Duval, F., Mokrani, M.-C., and Monreal-Ortiz, J.A. (2006). Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: Dopaminergic, noradrenergic and thyroid correlates. Psychoneuroendocrinology, 31, 876–888.
Endicott, J., Nee, J., Andreasen, N.et al. (1985). Bipolar II. Combine or keep separate?Journal of Affective Disorders, 8, 17–28.
Ettner, S.L. and Hermann, R.C. (1998). Inpatient psychiatric treatment of elderly Medicare beneficiaries. Psychiatric Services, 49, 1173–1179.
Flint, A.J. and Rifat, S.L. (1998). Two-year outcome of psychotic depression in late life. American Journal of Psychiatry, 155, 178–183.
Folstein, M.F., Folstein, S.E., and McHugh, P.R. (1975). Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
Forty, L., Jones, L., Jones, I.et al. (2009). Is depression severity the sole cause of psychotic symptoms during an episode of unipolar major depression? A study both between and within subjects. Journal of Affective Disorders, 114, 103–109.
Frances, A., Brown, R.P., Kocsis, J.H.et al. (1981). Psychotic depression: A distinct entity?American Journal of Psychiatry, 138, 831–833.
Friedman, C., Mowbray, M.S., and Hamilton, V.J. (1961). Imipramine (Tofranil) in depressive states. Journal of Mental Science, 107, 948–953.
Garis, R.I. and Farmer, K.C. (2002). Examining costs of chronic conditions in a Medicaid population. Managed Care, 11, 43–50.
Gaudiano, B.A., Dalrymple, K.L., and Zimmerman, M. (2009). Prevalence and clinical characteristics of psychotic versus nonpsychotic major depression in a general psychiatric outpatient clinic. Depression and Anxiety, 26, 54–64.
Glassman, A. and Roose, S. (1981). Delusional depression. Archives of General Psychiatry, 38, 424–427.
Glassman, A.H., Perel, J.M., Shostak, M., Kantor, S.J., and Fleiss, J.L. (1977). Clinical implications of imipramine plasma levels for depressive illness. Archives of General Psychiatry, 34, 197–204.
Goes, F.S., Sadler, B., Toolan, J.et al. (2007). Psychotic features in bipolar and unipolar depression. Bipolar Disorders, 9, 901–906.
Guze, S.B., Woodruff, R.A., and Clayton, P.J. (1975). The significance of psychotic affective disorders. Archives of General Psychiatry, 32, 1147–1150.
Hoch, A. and MacCurdy, J.T. (1922). The prognosis of involutionary melancholia. Archives of Neurology and Psychiatry, 7, 1–17.
Hordern, A., Holt, N.F., Burt, C.G.et al. (1963). Amitriptyline in depressive states. British Journal of Psychiatry, 109, 815–825.
Johnson, J., Horwath, E., and Weissman, M.M. (1991). The validity of major depression with psychotic features based on a community sample. Archives of General Psychiatry, 48, 1075–1081.
Kellner, C.H., Knapp, R., Petrides, G.et al. (2006). Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression. Archives of General Psychiatry, 63, 1337–1344.
Kendler, K.S. (1991). Mood-incongruent psychotic affective illness. Archives of General Psychiatry, 48, 362–369.
Kocsis, J.H., Croughan, J.L., Katz, M.M.et al. (1990). Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression. American Journal of Psychiatry, 147, 621–624.
Kraepelin, E. (Diefendorf, A.R., trans.) (1907). Clinical Psychiatry: A Textbook for Students and Physicians. New York, NY: Macmillan Publishing Co. Inc.
Kroessler, D. (1985). Relative efficacy rates for therapies of delusional depression. Convulsive Therapy, 1, 173–182.
Lewis, A.J. (1934). Melancholia: a clinical survey of depressive states. Journal of Medical Science, 80, 277–378.
Lykouras, E., Malliaras, D., Christodoulou, G.N.et al. (1986). Delusional depression: Phenomenology and response to treatment, a prospective study. Acta Psychiatric a Scandinavica, 73, 324–329.
Maj, M., Pirozzi, R., and Di CaprioE. (1990). Major depression with mood-congruent psychotic features: a distinct diagnostic entity or a more severe subtype of depression?Acta Psychiatrica Scandinavica, 82, 439–444.
Maj, M., Pirozzi, R., and Magliano, L. (2007). Phenomenology and prognostic significance of delusions in major depressive disorder: A 10-year prospective follow-up study. Journal of Clinical Psychiatry, 68, 1411–1417.
Meyers, B.S. and Greenberg, R. (1986). Late-life delusional depression. Journal of Affective Disorders, 11, 133–137.
Meyers, B.S., Klimstra, S.A., Gabriele, M.et al. (2001). Continuation treatment of delusional depression in older adults. American Journal of Geriatric Psychiatry, 9, 415–422.
Meyers, B.S., English, J.M., Peasley-Micklus, C.et al. (2006). Delusion assessment scale for psychotic major depression: Reliability, validity and utility. Biological Psychiatry, 60, 1336–1342.
Meyers, B.S., Flint, A.J., Rothschild, A.J.et al. (2009). A double-blind randomized controlled trial of olanzapine plus sertraline vs. olanzapine plus placebo for psychotic depression: The Study of Pharmacotherapy of Psychotic Depression (STOP-PD). Archives of General Psychiatry, 66, 838–847.
Mugdha, T., Hays, J., and Krishnan, K.R.R. (1999). Clinical, demographic and social characteristics of psychotic depression. Psychiatric Research, 86, 99–106.
Mulsant, B.H., Sweet, R.A., Rosen, J.et al. (2001). A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life. Journal of Clinical Psychiatry, 62, 597–604.
Naz, B., Craig, T.J., Bromet, E.J.et al. (2007). Remission and relapse after the first hospital admission in psychotic depression: A 4-year naturalistic follow-up. Psychological Medicine, 37, 1173–1181.
Nelson, J.C. and Davis, J.M. (1997). DST studies in psychotic depression: A meta-analysis. American Journal of Psychiatry, 154, 1497–1503.
Nelson, J.C., Price, L.H., and Jatlow, P.I. (1986). Neuroleptic dose and desipramine concentrations during combined treatment of unipolar delusional depression. American Journal of Psychiatry, 143, 1151–1154.
Ohayon, M.M. and Schatzberg, A.F. (2002). Prevalence of depressive episodes with psychotic features in the general population. American Journal of Psychiatry, 159, 1855–1861.
Olfson, M., Marcus, S., Sackeim, H.A.et al. (1998). Use of ECT for the inpatient treatment of recurrent depression. American Journal of Psychiatry, 155, 22–29.
Parker, G., Roy, K., Hadzi-Pavlovic, D., and PedicF. (1992). Psychotic (delusional) depression: A meta-analysis of physical treatments. Journal of Affective Disorders, 24, 17–24.
Parker, G., Hadzi-Pavlovic, D., Hickie, I.et al. (1991). Distinguishing psychotic and non-psychotic melancholia. Journal of Affective Disorders, 22, 135–148.
Petrides, G., Fink, M., Husain, M.M.et al. (2001). ECT remission rates in psychotic versus nonpsychotic depressed patients: A report from CORE. Journal of ECT, 17, 244–253.
Pope, H.G., Jr., and Lipinski, J.F. (1978). Diagnosis in schizophrenia and manic-depressive illness: Reassessment of the specificity of “schizophrenic” symptoms in the light of current research. Archives of General Psychiatry, 35, 811–828.
Robinson, D.G. and Spiker, D.G. (1985). Delusional depression: A one-year follow-up. Journal of Affective Disorders, 9, 79–83.
Roose, S.P., Glassman, T., Woodring, S., and Vital-Herne, J. (1983). Depression, delusions and suicide. American Journal of Psychiatry, 140, 1159–1162.
Rothschild, A.J. and Duval, S.E. (2003). How long should patients with psychotic depression stay on the antipsychotic medication?Journal of Clinical Psychiatry, 64, 390–396.
Rothschild, A.J., Williamson, D.J., Tohen, M.F.et al. (2004). A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features. Journal of Clinical Psychopharmacology, 24, 365–373.
Rothschild, A.J., Winer, J., Flint, A.J.et al. (2008). Missed diagnosis of psychotic depression at 4 academic centers. Journal of Clinical Psychiatry, 69, 1293–1296.
Ruggerior, C.J., Kotov, R., and Carlson, G.A. (2011). Diagnostic consistency of major depression with psychosis across 10 years. Journal of Clinical Psychiatry, 72, 1207–1213.
Sackeim, H.A., Haskett, R.F., Mulsant, B.H.et al. (2001). Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: A randomized controlled trial. Journal of the American Medical Association, 285, 1299–1307.
Serretti, A., Lattuada, E., Cusin, C.et al. (1999). Clinical and demographic features of psychotic and nonpsychotic depression. Comprehensive Psychiatry, 40, 358–362.
Schatzberg, A.F. and Rothschild, A.J. (1992). Psychotic (delusional) major depression: Should it be included as a distinct syndrome in DSM-IV?American Journal of Psychiatry, 149, 733–745.
Schatzberg, A.F., Rothschild, A.J., Langlais, P.J.et al. (1985). A corticosteroid/dopamine hypothesis for psychotic depression and related states. Journal of Psychiatric Research, 19, 57–64.
Schneider, K.(Hamilton, M.W., trans.) (1959). Clinical Psychopathology. New York, NY: Grune and Stratton Inc.
Simpson, G.M., El Sheshai, A., Rady, A.et al. (2003). Sertraline as monotherapy in the treatment of psychotic and nonpsychotic depression. Journal of Clinical Psychiatry, 64, 959–965.
Spiker, D. and Kupfer, D. (1988). Placebo response rates in psychotic and nonpsychotic depression. Journal of Affective Disorders, 14, 21–23.
Spiker, D.G., Stein, J., and Rich, C.L. (1985). Delusional depression and electroconvulsive therapy. One year later. Convulsive Therapy, 1, 167–172.
Spiker, D.G., Weiss, J.C., Dealy, R.S.et al. (1986). The pharmacological treatment of delusional depression. American Journal of Psychiatry, 142, 430–436.
Spitzer, R.L., Endicott, J., and Robins, E. (1975). Research Diagnostic Criteria for a Selected Group of Functional Disorders, Second Edition. New York, NY: New York State Psychiatric Institute.
Strober, M. and Carlson, G. (1982). Bipolar illness in adolescents with major depression. Archives of General Psychiatry, 39, 549–555.
Suominen, K., Haukka, J., Valtonen, H.M., and Lönnqvist, J. (2009). Outcome of patients with major depressive disorder after serious suicide attempt. Journal of Clinical Psychiatry, 70, 1372–1378.
Thakur, M., Hays, J., and Krishnan, R.R. (1999). Clinical, demographic and social characteristics of psychotic depression. Psychiatry Research, 86, 99–106.
Van den Broek, W.W., Birkenhager, T.K., Mulder, P.G.H.et al. (2004). A double-blind study of comparing imipramine with fluvoxamine in depressed inpatients. Psychopharmacology, 175, 481–486.
Vythilingam, M., Chen, J., Bremner, J.D.et al. (2003). Psychotic depression and mortality. American Journal of Psychiatry, 160, 574–576.
Weissman, M.M., Prusoff, B.A., and Merikangas, K.R. (1984). Is delusional depression related to bipolar disorder?American Journal of Psychiatry, 141, 892–893.
Wijkstra, J., Lijmer, J., Balk, F.J.et al. (2006). Pharmacological treatment of unipolar psychotic depression. British Journal of Psychiatry, 188, 410–415.
Wijkstra, J., Burger, H., Van den Broek, W.W.et al. (2010a). Long-term response to acute pharmacological treatment of psychotic depression. Journal of Affective Disorders, 123, 238–242.
Wijkstra, J., Burther, H., Van den Broek, W.W.et al. (2010b). Treatment of unipolar psychotic depression: A randomized, double-blind study comparing imipramine, venlafaxine and venlafaxine plus quetiapine. Acta Psychiatrica Scandinavica, 121, 190–200.